APA

Escherich G., Zimmermann M. & Janka-Schaub G. (20130306). Doxorubicin or daunorubicin given upfront in a therapeutic window are equally effective in children with newly diagnosed acute lymphoblastic leukemia. A randomized comparison in trial CoALL 07-03. : Pediatric blood & cancer.

Chicago

Escherich Gabriele, Zimmermann Martin and Janka-Schaub Gritta. 20130306. Doxorubicin or daunorubicin given upfront in a therapeutic window are equally effective in children with newly diagnosed acute lymphoblastic leukemia. A randomized comparison in trial CoALL 07-03. : Pediatric blood & cancer.

Harvard

Escherich G., Zimmermann M. and Janka-Schaub G. (20130306). Doxorubicin or daunorubicin given upfront in a therapeutic window are equally effective in children with newly diagnosed acute lymphoblastic leukemia. A randomized comparison in trial CoALL 07-03. : Pediatric blood & cancer.

MLA

Escherich Gabriele, Zimmermann Martin and Janka-Schaub Gritta. Doxorubicin or daunorubicin given upfront in a therapeutic window are equally effective in children with newly diagnosed acute lymphoblastic leukemia. A randomized comparison in trial CoALL 07-03. : Pediatric blood & cancer. 20130306.